NCT05471492: A trial that was reported late by Pfizer
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT05471492 |
|---|---|
| Title | A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN LABEL CHRONIC TREATMENT PERIOD TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF PF-06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE CROHN'S DISEASE |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 30, 2023 |
| Completion date | Aug. 15, 2026 |
| Required reporting date | Aug. 15, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 24, 2023 |
| Days late | None |